Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations

MP Cadiz, KA Gibson, KT Todd, DG Nascari… - Journal of Experimental …, 2024 - rupress.org
Aducanumab, an anti-amyloid immunotherapy for Alzheimer's disease, efficiently reduces
Aβ, though its plaque clearance mechanisms, long-term effects, and effects of …

Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations.

MP Cadiz, KA Gibson, KT Todd, DG Nascari… - The Journal of …, 2024 - europepmc.org
Aducanumab, an anti-amyloid immunotherapy for Alzheimer's disease, efficiently reduces
Aβ, though its plaque clearance mechanisms, long-term effects, and effects of …

Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations

MP Cadiz, KA Gibson, KT Todd, DG Nascari, N Massa… - 2024 - digitalcommons.wustl.edu
Aducanumab, an anti-amyloid immunotherapy for Alzheimer's disease, efficiently reduces
Aβ, though its plaque clearance mechanisms, long-term effects, and effects of …

Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations

MP Cadiz, KA Gibson, KT Todd… - The Journal of …, 2024 - profiles.wustl.edu
Aducanumab, an anti-amyloid immunotherapy for Alzheimer's disease, efficiently reduces
Aβ, though its plaque clearance mechanisms, long-term effects, and effects of …

Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations

MP Cadiz, KA Gibson, KT Todd… - The Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Aducanumab, an anti-amyloid immunotherapy for Alzheimer's disease, efficiently reduces
Aβ, though its plaque clearance mechanisms, long-term effects, and effects of …